Pregnancy and childbirth after treatment with autologous hematopoietic stem cell transplantation for severe systemic sclerosis requiring parenteral nutrition. Ethical issues

Clinical and Experimental Rheumatology

Volumn 26, Issue 6, 2008, Pages 1122-1124

  Tyndall, Anthony J ^a   Joly, Francisca ^b   Carbonne, Bruno ^c   Deligny, Christophe N ^d   Farge, Dominique C ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b BEAUJON HOSPITAL   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

Author keywords

Cyclophosphamide; Ethics; Fertility; Parenteral nutrition; Pregnancy; Stem cell transplantation; Systemic sclerosis

Indexed keywords

AMLODIPINE; ANTINUCLEAR ANTIBODY; BETAMETHASONE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; ERYTHROMYCIN; GRANULOCYTE COLONY STIMULATING FACTOR; NIFEDIPINE; OCTREOTIDE; THYMOCYTE ANTIBODY; WARFARIN;

ABSENCE OF SIDE EFFECTS; ADULT; ARTHRITIS; ARTICLE; ARTIFICIAL VENTILATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CARDIOPULMONARY INSUFFICIENCY; CASE REPORT; CATHETER INFECTION; CAUSE OF DEATH; CD34 SELECTION; CESAREAN SECTION; CHILDBIRTH; CURETTAGE; DELIVERY; DISEASE COURSE; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATALITY; FEMALE; FETUS LUNG MATURATION; FOLLOW UP; GASTROINTESTINAL DISEASE; GASTROINTESTINAL OBSTRUCTION; GENERAL CONDITION DETERIORATION; HOME CARE; HUMAN; LUNG FIBROSIS; MATERNAL CARE; MATERNAL HYPERTENSION; MATERNAL WELFARE; MEDICAL ETHICS; MYELOABLATIVE CONDITIONING; NEGRO; NEWBORN; NURSING CARE; NUTRITIONAL STATUS; ONSET AGE; PARENTERAL NUTRITION; PERICARDITIS; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RAYNAUD PHENOMENON; RECURRENT INFECTION; RESPIRATORY DISTRESS SYNDROME; SCORING SYSTEM; SKIN DEFECT; SPONTANEOUS ABORTION; STEM CELL MOBILIZATION; SYSTEMIC SCLEROSIS; TREATMENT RESPONSE;

ADULT; ETHICS, MEDICAL; FATAL OUTCOME; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT, NEWBORN; PARENTERAL NUTRITION; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROGNOSIS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

EID: 59149106222     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. LEROY EC, BLACK C, FLEISCHMAJER R et al.: Scleroderma (Systemic-Sclerosis) - Classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
2. STEEN VD, MEDSGER TA: Fertility and pregnancy outcome in women with systemic sclerosis. Arthritis Rheum 1999; 42: 763-8.
3. STEEN VD: Pregnancy in scleroderma. Rheum Dis Clin North Am 2007; 33: 345-58, vii.
4. SCUSSEL-LONZETTI L, JOYAL F, RAYNAULD JP et al.: Predicting mortality in systemic sclerosis: Analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore). 2002; 81: 154-67.
5. FARGE D, PASSWEG J, VAN LAAR JM et al.: Autologous stem cell transplantation in the treatment of systemic sclerosis: Report from the EBMT/EULAR Registry. Ann Rheum Dis 2004; 63: 974-81.
6. VONK MC, MARJANOVIC Z, VAN DEN HOOGEN FH et al.: Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis. Ann Rheum Dis 2008; 67: 98-104.
7. SANDERS JE, HAWLEY J, LEVY W et al.: Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996; 87: 3045-52.
8. GEORGES C, CHASSANY O, MOUTHON L et al.: Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ). Clin Rheumatol 2005; 24: 3-10
9. GOMEZ O, FIGUERAS F, MARTINEZ JM et al.: Sequential changes in uterine artery blood flow pattern between the first and second trimesters of gestation in relation to pregnancy outcome. Ultrasound Obstet Gynecol 2006; 28: 802-8.
10. KING JF, FLENADY VJ, PAPATSONIS DN, DEKKER GA, CARBONNE B: Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2003: CD002255.
11. SANDERS JE, HAWLEY J, LEVY W et al.: Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996; 87: 3045-52.
12. SALOOJA N, SZYDLO RM, SOCIE G et al.; LATE EFFECTS WORKING PARTY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION. Pregnancy outcomes after peripheral blood or bone marrow transplantation: A retrospective survey. Lancet 2001; 358: 271-6.
13. MEIROW D, LEVRON J, ELDAR-GEVA T et al.: Monitoring the ovaries after autotransplantation of cryopreserved ovarian tissue: Endocrine studies, in vitro fertilization cycles, and live birth. Fertil Steril 2007; 87: 418.e7-418.e15.
14. CASTELO-BRANCO C, NOMDEDEU B, CAMUS A et al.: Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy. Fertil Steril 2007; 87: 702-5.
15. KING JF, FLENADY VJ, PAPATSONIS DN, DEKKER GA, CARBONNE B: Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2003; CD 002255.